Skip to main content
icon for 6月30日までに米国でエボラ出血熱の症例はありますか？

6月30日までに米国でエボラ出血熱の症例はありますか？

icon for 6月30日までに米国でエボラ出血熱の症例はありますか？

6月30日までに米国でエボラ出血熱の症例はありますか？

はい

<1% 確率
Polymarket

$328,219 Vol.

はい

<1% 確率
Polymarket

$328,219 Vol.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.**Trader consensus favoring "No" at 90.5% reflects the CDC's low-risk assessment for the Bundibugyo ebolavirus outbreak centered in remote DRC and Uganda regions, combined with rigorous U.S. entry screening and quarantine protocols that have prevented any imported cases as of mid-June 2026.** No confirmed Ebola cases linked to the outbreak have reached the United States despite hundreds of African infections, aided by enhanced airport monitoring at designated ports of entry, contact tracing, and policies directing exposed Americans to overseas facilities rather than domestic return. The virus requires direct contact with infectious bodily fluids, features a 2–21-day incubation period, and exhibits limited airborne transmission, making undetected community introduction improbable within the narrow 12-day window to June 30. Realistic challenges include a symptomatic traveler evading screening or an undetected exported case, though current epidemiological data and public-health infrastructure make such scenarios unlikely before resolution.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
音量
$328,219
終了日
2026/06/30
マーケット開始日
May 15, 2026, 3:04 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.

提案された結果: いいえ

異議申し立てなし

最終結果: いいえ

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.**Trader consensus favoring "No" at 90.5% reflects the CDC's low-risk assessment for the Bundibugyo ebolavirus outbreak centered in remote DRC and Uganda regions, combined with rigorous U.S. entry screening and quarantine protocols that have prevented any imported cases as of mid-June 2026.** No confirmed Ebola cases linked to the outbreak have reached the United States despite hundreds of African infections, aided by enhanced airport monitoring at designated ports of entry, contact tracing, and policies directing exposed Americans to overseas facilities rather than domestic return. The virus requires direct contact with infectious bodily fluids, features a 2–21-day incubation period, and exhibits limited airborne transmission, making undetected community introduction improbable within the narrow 12-day window to June 30. Realistic challenges include a symptomatic traveler evading screening or an undetected exported case, though current epidemiological data and public-health infrastructure make such scenarios unlikely before resolution.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
音量
$328,219
終了日
2026/06/30
マーケット開始日
May 15, 2026, 3:04 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.

提案された結果: いいえ

異議申し立てなし

最終結果: いいえ

関連

icon for Will South Sudan have an Ebola case in 2026?

Will South Sudan have an Ebola case in 2026?

64%
icon for Ebola pandemic in 2026?

Ebola pandemic in 2026?

3%
icon for 2026年7月31日までに米国で少なくとも2300件の麻疹症例が発生しますか？

2026年7月31日までに米国で少なくとも2300件の麻疹症例が発生しますか？

84%
はい

外部リンクに注意してください。

よくある質問

「6月30日までに米国でエボラ出血熱の症例はありますか？」はPolymarket上の2個の結果が可能な予測市場で、トレーダーが何が起こるかに基づいてシェアを売買します。現在のリード結果は「6月30日までに米国でエボラの症例は出るか？」で0%です。価格はコミュニティのリアルタイム確率を反映しています。例えば、0¢で取引されているシェアは、市場がその結果に0%の確率を集合的に割り当てていることを意味します。これらのオッズは継続的に変化します。正しい結果のシェアは市場決済時に各$1で引き換え可能です。

本日現在、「6月30日までに米国でエボラ出血熱の症例はありますか？」は$328.2Kの総取引量を生み出しています（May 15, 2026のマーケット開始以来）。この取引活動レベルはPolymarketコミュニティの強い関与を反映し、現在のオッズが幅広い市場参加者によって形成されていることを保証します。このページで直接、ライブの価格変動を追跡し、任意の結果で取引できます。

「6月30日までに米国でエボラ出血熱の症例はありますか？」で取引するには、このページに記載されている2個の利用可能な結果を閲覧します。各結果には市場の暗示確率を表す現在の価格が表示されています。ポジションを取るには、最も可能性が高いと思う結果を選び、「はい」で支持するか「いいえ」で反対するかを選択し、金額を入力して「取引」をクリックします。選んだ結果が市場決済時に正しければ、「はい」のシェアは各$1を支払います。正しくなければ$0です。決済前にいつでもシェアを売却できます。

これは非常に拮抗した市場です。「6月30日までに米国でエボラ出血熱の症例はありますか？」の現在のリーダーは「6月30日までに米国でエボラの症例は出るか？」でわずか0%です。どの結果も強い多数派を占めていないため、トレーダーはこれを非常に不確実と見ており、独自の取引機会を提供する可能性があります。これらのオッズはリアルタイムで更新されますので、このページをブックマークしてください。

「6月30日までに米国でエボラ出血熱の症例はありますか？」の決済ルールは、各結果が勝者と宣言されるために何が起こる必要があるかを正確に定義しています。これには結果を決定するために使用される公式データソースも含まれます。このページのコメント上にある「ルール」セクションで完全な決済基準を確認できます。取引前にルールを注意深く読むことをお勧めします。